Absence of functional alternative complement pathway alleviates lupus cerebritis (Q48157307)

9 February 2018

title

Absence of functional alternative complement pathway alleviates lupus cerebritis (English)

1 reference

9 February 2018

3

Paul Vezina

1 reference

9 February 2018

author name string

Jessy J Alexander

1

1 reference

9 February 2018

Alexander Jacob

2

1 reference

9 February 2018

Hideharu Sekine

4

1 reference

9 February 2018

Gary S Gilkeson

5

1 reference

9 February 2018

Richard J Quigg

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 June 2007

1 reference

9 February 2018

European Journal of Immunology

published in

1 reference

9 February 2018

volume

37

1 reference

9 February 2018

issue

6

1 reference

9 February 2018

page(s)

1691-1701

1 reference

9 February 2018

Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

Systemic lupus erythematosus, complement deficiency, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Factor B activation in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

The Bb fragment of complement factor B acts as a B cell growth factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Cooperative interaction of factor B and other complement components with mononuclear cells in the antibody-independent lysis of xenogeneic erythrocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Expression of a complete and functional complement system by human neuronal cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

A new apoptotic pathway for the complement factor B-derived fragment Bb

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Increased TUNEL staining in brains of autoimmune Fas-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Differential expression of fibronectin, tenascin-C and NCAMs in cultured hippocampal astrocytes activated by kainate, bacterial lipopolysaccharide or basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

The glial scar and central nervous system repair

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Microvascular damage following experimental sinus-vein thrombosis in rats

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

PTEN regulates Akt kinase activity in hippocampal neurons and increases their sensitivity to glutamate and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Neurobehavioral alterations in autoimmune mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

On the track of neuropsychiatric lupus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Cognition and immunity; antibody impairs memory

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Abrogation of the alternative complement pathway by targeted deletion of murine factor B

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-fas lpr mice--roles of intercellular adhesion molecule-1 and P-selectin.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Pathogenesis of systemic lupus erythematosus (SLE).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

The blood-brain barrier in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Features of systemic lupus erythematosus in Dnase1-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Systemic LPS injection leads to granulocyte influx into normal and injured brain: effects of ICAM-1 deficiency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Lymphocyte infiltration in the injured brain: role of proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Anti-intercellular adhesion molecule-1 (ICAM-1) antibody treatment prevents central and peripheral nervous system disease in autoimmune-prone mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

PKB/AKT: functional insights from genetic models

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Unravelling the activation mechanisms of protein kinase B/Akt

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

PTEN: from pathology to biology

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Reactive astrocytes in neural repair and protection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Immunohistochemical localization of extracellular matrix proteins in human glioma, both in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Behavioral heterogeneity in an animal model of neuropsychiatric lupus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636638

7 January 2021

Identifiers

DOI

10.1002/EJI.200636638

1 reference

9 February 2018

release_fxypc44xbneq5gfabg66wdnrky

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fxypc44xbneq5gfabg66wdnrky

24 November 2022

mapped directly with Wikidata item

1 reference

9 February 2018